Lee S Cohen

Array ( [id] => 6361548 [patent_doc_number] => 20020058657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => '2-[1H]-quinolone and 2-[1H]-quinoxalone inhibitors of factor Xa' [patent_app_type] => new [patent_app_number] => 09/773374 [patent_app_country] => US [patent_app_date] => 2001-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12599 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058657.pdf [firstpage_image] =>[orig_patent_app_number] => 09773374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1581737 [patent_doc_number] => 06423720 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Pyrimidine compounds and methods for making and using the same' [patent_app_type] => B1 [patent_app_number] => 09/775064 [patent_app_country] => US [patent_app_date] => 2001-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4253 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423720.pdf [firstpage_image] =>[orig_patent_app_number] => 09775064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1378308 [patent_doc_number] => 06559159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-06 [patent_title] => 'Kappa opioid receptor ligands' [patent_app_type] => B2 [patent_app_number] => 09/774566 [patent_app_country] => US [patent_app_date] => 2001-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10095 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/559/06559159.pdf [firstpage_image] =>[orig_patent_app_number] => 09774566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1400188 [patent_doc_number] => 06537948 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Uracil compounds and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/774116 [patent_app_country] => US [patent_app_date] => 2001-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56179 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537948.pdf [firstpage_image] =>[orig_patent_app_number] => 09774116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043778 [patent_doc_number] => 06867211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-15 [patent_title] => '4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy' [patent_app_type] => utility [patent_app_number] => 10/182579 [patent_app_country] => US [patent_app_date] => 2001-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15702 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867211.pdf [firstpage_image] =>[orig_patent_app_number] => 10182579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1181579 [patent_doc_number] => 06737425 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-18 [patent_title] => 'N,N-substituted cyclic amine derivatives' [patent_app_type] => B1 [patent_app_number] => 09/743358 [patent_app_country] => US [patent_app_date] => 2001-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 63027 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/737/06737425.pdf [firstpage_image] =>[orig_patent_app_number] => 09743358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231733 [patent_doc_number] => 06693101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'v integrin receptor antagonists' [patent_app_type] => B2 [patent_app_number] => 09/767471 [patent_app_country] => US [patent_app_date] => 2001-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38524 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 533 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693101.pdf [firstpage_image] =>[orig_patent_app_number] => 09767471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874934 [patent_doc_number] => 20030195231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Compounds exhibiting thrombopoietin receptor agonism' [patent_app_type] => new [patent_app_number] => 10/169362 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 160654 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20030195231.pdf [firstpage_image] =>[orig_patent_app_number] => 10169362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6408448 [patent_doc_number] => 20020037889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Alpha V integrin receptor antagonists' [patent_app_type] => new [patent_app_number] => 09/766148 [patent_app_country] => US [patent_app_date] => 2001-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26455 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037889.pdf [firstpage_image] =>[orig_patent_app_number] => 09766148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6624575 [patent_doc_number] => 20020016328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Corticotropin releasing factor antagonists' [patent_app_type] => new [patent_app_number] => 09/761995 [patent_app_country] => US [patent_app_date] => 2001-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53651 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016328.pdf [firstpage_image] =>[orig_patent_app_number] => 09761995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514794 [patent_doc_number] => 06420367 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Pyrimidine derivatives exhibiting antitumor activity' [patent_app_type] => B1 [patent_app_number] => 09/743721 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44872 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420367.pdf [firstpage_image] =>[orig_patent_app_number] => 09743721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645585 [patent_doc_number] => 06472384 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Antimicrobial compounds' [patent_app_type] => B1 [patent_app_number] => 09/757393 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65586 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472384.pdf [firstpage_image] =>[orig_patent_app_number] => 09757393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5845420 [patent_doc_number] => 20020132828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Kappa opioid receptor ligands' [patent_app_type] => new [patent_app_number] => 09/755021 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10581 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132828.pdf [firstpage_image] =>[orig_patent_app_number] => 09755021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436002 [patent_doc_number] => 06355645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-03-12 [patent_title] => 'Lipid-lowering quinazoline derivative' [patent_app_type] => B2 [patent_app_number] => 09/756483 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 7026 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355645.pdf [firstpage_image] =>[orig_patent_app_number] => 09756483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478893 [patent_doc_number] => 06451843 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Arylphenyl-substituted cyclic keto enols' [patent_app_type] => B1 [patent_app_number] => 09/673907 [patent_app_country] => US [patent_app_date] => 2001-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30692 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 392 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451843.pdf [firstpage_image] =>[orig_patent_app_number] => 09673907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1240332 [patent_doc_number] => 06686382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-03 [patent_title] => 'Sulfonamides and derivatives thereof that modulate the activity of endothelin' [patent_app_type] => B2 [patent_app_number] => 09/751825 [patent_app_country] => US [patent_app_date] => 2000-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33382 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 286 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686382.pdf [firstpage_image] =>[orig_patent_app_number] => 09751825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936697 [patent_doc_number] => 20020061896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Imidazopyrimidine nucleoside analogues with anti-HIV activity' [patent_app_type] => new [patent_app_number] => 09/751488 [patent_app_country] => US [patent_app_date] => 2000-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19675 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061896.pdf [firstpage_image] =>[orig_patent_app_number] => 09751488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514805 [patent_doc_number] => 06420372 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Febrifugine, isofebrifugine and method for producing the same' [patent_app_type] => B1 [patent_app_number] => 09/674362 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3050 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420372.pdf [firstpage_image] =>[orig_patent_app_number] => 09674362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470217 [patent_doc_number] => 06407089 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Triazatrinaphthyrins and the use thereof' [patent_app_type] => B1 [patent_app_number] => 09/742293 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5647 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407089.pdf [firstpage_image] =>[orig_patent_app_number] => 09742293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1348370 [patent_doc_number] => 06583179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-24 [patent_title] => 'Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone' [patent_app_type] => B2 [patent_app_number] => 09/745283 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31756 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1019 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583179.pdf [firstpage_image] =>[orig_patent_app_number] => 09745283 [rel_patent_id] =>[rel_patent_doc_number] =>)